1. Home
  2. ANY vs VIVS Comparison

ANY vs VIVS Comparison

Compare ANY & VIVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sphere 3D Corp.

ANY

Sphere 3D Corp.

HOLD

Current Price

$1.67

Market Cap

10.0M

Sector

Finance

ML Signal

HOLD

Logo VivoSim Labs Inc.

VIVS

VivoSim Labs Inc.

BUY

Current Price

$1.99

Market Cap

8.1M

Sector

Health Care

ML Signal

BUY

Company Overview

Basic Information
Metric
ANY
VIVS
Founded
N/A
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.0M
8.1M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
ANY
VIVS
Price
$1.67
$1.99
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$30.00
N/A
AVG Volume (30 Days)
94.0K
4.9M
Earning Date
03-27-2026
02-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$11,099,000.00
$140,000.00
Revenue This Year
N/A
$42.38
Revenue Next Year
$29.57
$15.42
P/E Ratio
N/A
N/A
Revenue Growth
N/A
35.92
52 Week Low
$1.53
$1.41
52 Week High
$12.60
$21.96

Technical Indicators

Market Signals
Indicator
ANY
VIVS
Relative Strength Index (RSI) 91.87 46.96
Support Level $0.16 $1.82
Resistance Level $0.26 $2.89
Average True Range (ATR) 0.06 0.34
MACD 0.09 -0.01
Stochastic Oscillator 85.41 15.68

Price Performance

Historical Comparison
ANY
VIVS

About ANY Sphere 3D Corp.

Sphere 3D Corp provides solutions for stand-alone storage and technologies that converge the traditional silos of compute, storage, and network into integrated hyper-converged or converged solution. Its Disk systems include HVE Converged and Hyper-converged Infrastructure. It generates the majority of its revenue from the services it offers. All of its revenue comes from the Americas. The Company has two operating segments: Bitcoin Mining and Service and Product. The Bitcoin Mining segment generates revenue from the digital currency, it earns through its bitcoin mining activities. The Service and Product segment generates revenue from long-term customer contracts for service contracts and extended service contract and the sale of products related to the Company's data storage product line.

About VIVS VivoSim Labs Inc.

VivoSim Labs Inc formerly, Organovo Holdings Inc is a biotechnology company focused on developing FXR314 in inflammatory bowel disease (IBD), including ulcerative colitis (UC), based on demonstration of clinical promise in three-dimensional (3D) human tissues as well as preclinical data. FXR is a mediator of gastrointestinal and liver diseases. It is now offering liver toxicology predictive screening and research services as well as working on predicting and studying the intestinal side effect profiles of drugs that are therapeutic candidates of pharmaceutical and biotech companies at all stages of drug development.

Share on Social Networks: